Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Havencrest Capital Management is a Dallas-based lower middle-market private equity investment firm focused exclusively on the healthcare industry. Founded in 2018, the firm invests in and builds healthcare companies across sectors such as behavioral health, healthcare services, post-acute care, medical products, pharma services, payor services, physician-led practices, and technology-enabled services. Havencrest primarily pursues buyouts, recapitalizations, and growth equity investments in founder-led healthcare businesses rather than developing proprietary therapeutics. Its portfolio has included platforms and investments such as Avid Health at Home, Deep Centered Mental Health, Tekton Research, Paradigm Health, Focus Staff Services, ThermoTek, and The Oncology Institute. The firm deploys capital through dedicated healthcare funds, including Havencrest Healthcare Partners II, a $356 million fund raised in 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Havencrest Capital Management.